StockData
Outset Medical, Inc. logo

Outset Medical, Inc. (OM) stock

OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3075% below fair value
$3.16−0.23 (-6.78%)

Close on Nov 17, 2026Market cap $59.40MP/E –Yield –

Outset Medical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Outset Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$38.32M. For fiscal 2025 it was -$46.33M. The highest annual figure on record is -$46.33M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$46.33M–
FY2024Dec 31, 2024-$116.30M–
FY2023Dec 31, 2023-$131.37M–
FY2022Dec 31, 2022-$145.73M–
FY2021Dec 31, 2021-$130.26M–
FY2020Dec 31, 2020-$99.02M–
FY2019Dec 31, 2019-$70.29M–
FY2018Dec 31, 2018-$46.44M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.64M–
Q1 FY2026Mar 31, 2026-$12.84M–
Q4 FY2025Dec 31, 2025-$9.52M–
Q3 FY2025Sep 30, 2025-$6.32M–
Q2 FY2025Jun 30, 2025-$4.82M–
Q1 FY2025Mar 31, 2025-$25.66M–
Q4 FY2024Dec 31, 2024-$16.49M–
Q3 FY2024Sep 30, 2024-$20.57M–
Q2 FY2024Jun 30, 2024-$33.34M–
Q1 FY2024Mar 31, 2024-$45.91M–
Q4 FY2023Dec 31, 2023-$24.44M–
Q3 FY2023Sep 30, 2023-$34.00M–
Q2 FY2023Jun 30, 2023-$28.18M–
Q1 FY2023Mar 31, 2023-$44.76M–
Q4 FY2022Dec 31, 2022-$34.51M–
Q3 FY2022Sep 30, 2022-$34.31M–
Q2 FY2022Jun 30, 2022-$38.58M–
Q1 FY2022Mar 31, 2022-$38.34M–
Q4 FY2021Dec 31, 2021-$32.68M–
Q3 FY2021Sep 30, 2021-$28.13M–
Q2 FY2021Jun 30, 2021-$30.84M–
Q1 FY2021Mar 31, 2021-$38.62M–
Q4 FY2020Dec 31, 2020-$25.84M–
Q3 FY2020Sep 30, 2020-$29.12M–
Q2 FY2020Jun 30, 2020-$19.17M–
Q1 FY2020Mar 31, 2020-$24.89M–
Q4 FY2019Dec 31, 2019-$15.19M–

More Outset Medical figures

See a number that looks wrong?